T cell receptor (TCR) dependent activation induced marker (AIM) assays was employed to identify and quantify SARS-CoV-2-specific CD4+ T-cells in COVID-19 patients, while for CD8+ T-cells both AIM and intracellular cytokine staining (ICS) assays were used. This evidence concerns the gene CD8A and COVID-19.